A Study to Assess Efficacy and Safety of Wangbi Capsule in Patients With Rheumatoid Arthritis

A Study to Assess Efficacy and Safety of Wangbi Capsule in Patients With Rheumatoid Arthritis

The aim of this multi-center, prospective, non-interventional cohort study is to evaluate the efficacy and safety of Wangbi capsule for rheumatoid arthritis patients in the real-world setting.

Inclusion Criteria:

• Subject has a diagnosis of RA as defined by the ACR/EULAR 2010 classification criteria
• Patients older than 18
• Syndrome of insufficiency of liver and kidney or syndrome of cold and dampness defined by traditional Chinese medicine

Exclusion Criteria:

• Patients who are pregnant or breast feeding at enrolment
• History of malignancy prior to screening
• Patients with severe or poorly controlled chronic diseases such as hypertension, diabetes and coronary heart disease
• Patients taking biological agents, > 10mg prednisone (or equivalent amount of other glucocorticoids) ，more than 2 kinds of DMARDs or similar TCM drug like Wangbi Capsule